Related Experiment Videos
Hypothyroidism, an important cause of reversible hyperlipidemia
Clinica Chimica Acta; International Journal of Clinical Chemistry
|January 17, 1977
Summary
Primary hypothyroidism is a common cause of reversible hyperlipidemia. Treatment with L-thyroxine effectively normalized cholesterol and triglyceride levels in most patients, highlighting the importance of thyroid screening for lipid disorders.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Cardiovascular Health
Background:
- Primary hypothyroidism is identified as the underlying cause of hyperlipidemia in a cohort of 22 patients.
- The study population comprised individuals with a mean age of 46 years, predominantly males (59%), with significant comorbidities including vascular disease (27%) and xanthomas (14%).
- A high prevalence of thyroid antibodies (86%) suggests an autoimmune etiology in many cases, with familial clustering observed in 3 instances.
Purpose of the Study:
- To investigate the role of primary hypothyroidism as a cause of hyperlipidemia.
- To evaluate the efficacy of L-thyroxine treatment in managing hyperlipidemia associated with hypothyroidism.
- To assess the impact of thyroid hormone replacement on lipid profiles and associated cardiovascular risk factors.
Main Methods:
- A cohort of 22 patients diagnosed with primary hypothyroidism and hyperlipidemia were enrolled.
- Patients were treated with L-thyroxine at doses ranging from 0.05 to 0.2 mg/day for an average of 16 months.
- Lipoprotein phenotyping was performed to characterize the types of hyperlipidemia, and plasma cholesterol and triglyceride levels were monitored before and after treatment.
Main Results:
- Combined hyperlipidemia was prevalent (77%), with lipoprotein phenotypes IIB, IIA, III, and IV identified.
- L-thyroxine treatment normalized plasma cholesterol (<265 mg/dl) in 91% and triglycerides (<200 mg/dl) in 86% of patients.
- Significant reductions in mean fasting plasma cholesterol (387 to 205 mg/dl) and triglycerides (328 to 133 mg/dl) were observed (p<0.005).
Conclusions:
- Primary hypothyroidism is a frequent and reversible cause of hyperlipidemia.
- L-thyroxine therapy is highly effective in normalizing lipid levels in hypothyroid patients.
- Thyroid screening is crucial for identifying and managing hyperlipidemia, with potential benefits for cardiovascular health. Family screening aids in identifying autoimmune thyroid disease.